Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Diuretic

From Wikipedia, the free encyclopedia
Substance that promotes the production of urine
Diuretics
Drug class
Furosemide 125 mg vials forintravenous application
Class identifiers
UseForced diuresis,hypertension
ATC codeC03
External links
MeSHD004232
Legal status
In Wikidata

Adiuretic (/ˌdjʊˈrɛtɪk/) is any substance that promotesdiuresis, the increased production ofurine. This includesforced diuresis. A diuretic tablet is sometimes colloquially called awater tablet. There are several categories of diuretics. All diuretics increase the excretion ofwater from the body, through thekidneys. There exist several classes of diuretic, and each works in a distinct way. Alternatively, anantidiuretic, such asvasopressin (antidiuretic hormone), is an agent or drug which reduces the excretion of water in urine.

Medical uses

[edit]

Inmedicine, diuretics are used to treatheart failure,liver cirrhosis,hypertension,influenza,water poisoning, and certainkidney diseases. Some diuretics, such asacetazolamide, help to make theurine morealkaline, and are helpful in increasingexcretion of substances such asaspirin in cases ofoverdose or poisoning. Diuretics are sometimes abused by people with aneating disorder, especially people withbulimia nervosa, with the goal of losing weight.[citation needed]

Theantihypertensive actions of some diuretics (thiazides andloop diuretics in particular) are independent of their diuretic effect.[1][2] That is, the reduction in blood pressure is not due to decreased blood volume resulting from increasedurine production, but occurs through other mechanisms and at lower doses than that required to producediuresis.Indapamide was specifically designed with this in mind, and has a largertherapeutic window forhypertension (without pronounced diuresis) than most other diuretics.[citation needed]

Types

[edit]

High-ceiling/loop diuretics

[edit]

High-ceiling diuretics may cause a substantial diuresis – up to 20%[3] of the filtered load ofNaCl (salt) and water. This is large in comparison to normalrenal sodium reabsorption which leaves only about 0.4% of filtered sodium in the urine.Loop diuretics have this ability, and are therefore often synonymous with high-ceiling diuretics. Loop diuretics, such asfurosemide, inhibit the body's ability to reabsorbsodium at the ascending loop in thenephron, which leads to an excretion of water in the urine, whereas water normally follows sodium back into the extracellular fluid. Other examples of high-ceiling loop diuretics includeethacrynic acid andtorasemide.[citation needed]

Thiazides

[edit]

Thiazide-type diuretics such ashydrochlorothiazide act on the distal convoluted tubule and inhibit thesodium-chloride symporter leading to a retention of water in the urine, as water normally follows penetrating solutes. Frequent urination is due to the increased loss of water that has not been retained from the body as a result of a concomitant relationship with sodium loss from the convoluted tubule.The short-term anti-hypertensive action is based on the fact that thiazides decrease preload, decreasing blood pressure. On the other hand, the long-term effect is due to an unknownvasodilator effect that decreases blood pressure by decreasing resistance.[4]

Carbonic anhydrase inhibitors

[edit]

Carbonic anhydrase inhibitors inhibit the enzyme carbonic anhydrase which is found in the proximal convoluted tubule. This results in several effects including bicarbonate accumulation in the urine and decreased sodium absorption. Drugs in this class includeacetazolamide andmethazolamide.[citation needed]

Potassium-sparing diuretics

[edit]

These are diuretics which do not promote the secretion ofpotassium into the urine; thus, potassium is retained and not lost as much as with other diuretics.[citation needed] The term "potassium-sparing" refers to an effect rather than a mechanism or location; nonetheless, the term almost always refers to two specific classes that have their effect at similar locations:

Calcium-sparing diuretics

[edit]

The term "calcium-sparing diuretic" is sometimes used to identify agents that result in a relatively low rate of excretion ofcalcium.[5]

The reduced concentration of calcium in the urine can lead to an increased rate of calcium in serum. The sparing effect on calcium can be beneficial inhypocalcemia, or unwanted inhypercalcemia.[citation needed]

Thethiazides and potassium-sparing diuretics are considered to be calcium-sparing diuretics.[6]

  • The thiazides cause a netdecrease in calcium lost in urine.[7]
  • The potassium-sparing diuretics cause a netincrease in calcium lost in urine, but the increase ismuch smaller than the increase associated with other diuretic classes.[7]

By contrast, loop diuretics promote a significant increase in calcium excretion.[8] This can increase risk of reduced bone density.[9]

Osmotic diuretics

[edit]

Osmotic diuretics (e. g.,mannitol) are substances that increase osmolarity, but have limited tubular epithelial cell permeability. They work primarily by expanding extracellular fluid and plasma volume, therefore increasing blood flow to thekidney, particularly the peritubular capillaries. This reduces medullary osmolality and thus impairs the concentration of urine in theloop of Henle (which usually uses the high osmotic and solute gradient to transport solutes and water). Further, the limited tubular epithelial cell permeability increases osmolality and thus water retention in the filtrate.[10]

It was previously believed that the primary mechanism of osmotic diuretics such asmannitol is that they are filtered in theglomerulus, but cannot be reabsorbed. Thus their presence leads to an increase in the osmolarity of the filtrate and to maintain osmotic balance, water is retained in the urine.[citation needed]

Glucose, like mannitol, is a sugar that can behave as an osmotic diuretic. Unlike mannitol, glucose is commonly found in the blood. However, in certain conditions, such asdiabetes mellitus, the concentration of glucose in the blood (hyperglycemia) exceeds the maximum reabsorption capacity of the kidney. When this happens, glucose remains in the filtrate, leading to the osmotic retention of water in the urine.Glucosuria causes a loss of hypotonic water and Na+, leading to a hypertonic state with signs of volume depletion, such as dry mucosa, hypotension,tachycardia, and decreased turgor of the skin. Use of somedrugs, especiallystimulants, may also increase blood glucose and thus increase urination.[citation needed].

Low-ceiling diuretics

[edit]

The term "low-ceiling diuretic" is used to indicate a diuretic has a rapidly flatteningdose effect curve (in contrast to "high-ceiling", where the relationship is close to linear). Certain classes of diuretic are in this category, such as thethiazides.[11]

Mechanism of action

[edit]

Diuretics are tools of considerable therapeutic importance. First, they effectively reduceblood pressure. Loop and thiazide diuretics are secreted from the proximal tubule via the organic anion transporter-1 and exert their diuretic action by binding to the Na(+)-K(+)-2Cl(-) co-transporter type 2 in the thick ascending limb and the Na(+)-Cl(-) co-transporter in the distal convoluted tubule, respectively.[12]

Classification of common diuretics and their mechanisms of action.
ClassExamplesMechanismLocation (numbered in distance along nephron)
Ethanoldrinking alcoholInhibitsvasopressin secretion
WaterInhibitsvasopressin secretion
Acidifyingsaltscalcium chloride,ammonium chloride1.
Arginine vasopressin
receptor 2
 antagonists
amphotericin B,lithium[13][14]Inhibits vasopressin's action5.collecting duct
Selective vasopressin V2 antagonist (sometimes called aquaretics)tolvaptan,[15]conivaptanCompetitive vasopressin antagonism leads to decreased number of aquaporin channels in the apical membrane of the renal collecting ducts in kidneys, causing decreased water reabsorption. This causes an increase in renal free water excretion (aquaresis), an increase in serum sodium concentration, a decrease in urine osmolality, and an increase in urine output.[16]5.collecting duct
Na-H exchanger antagonistsdopamine[17]Promotes Na+ excretion2.proximal tubule[17]
Carbonic anhydrase inhibitorsacetazolamide,[17]dorzolamideInhibits H+ secretion, resultant promotion of Na+ and K+ excretion2.proximal tubule
Loop diureticsbumetanide,[17]ethacrynic acid,[17]furosemide,[17]torsemideInhibits theNa-K-2Cl symporter3. medullarythick ascending limb
Osmotic diureticsglucose (especially in uncontrolled diabetes),mannitolPromotes osmotic diuresis2.proximal tubule,descending limb
Potassium-sparing diureticsamiloride,spironolactone,eplerenone,triamterene,potassium canrenoate.Inhibition ofNa+/K+ exchanger: Spironolactone inhibitsaldosterone action, Amiloride inhibitsepithelial sodium channels[17]5.cortical collecting ducts
Thiazidesbendroflumethiazide,hydrochlorothiazideInhibits reabsorption byNa+/Cl symporter4.distal convoluted tubules
Xanthinescaffeine,theophylline,theobromineInhibits reabsorption of Na+, increaseglomerular filtration rate1. tubules

Caffeine when initially consumed in large quantities is both a diuretic and anatriuretic,[18] but this effect disappears with chronic consumption.[19][20][21]

Adverse effects

[edit]

The main adverse effects of diuretics arehypovolemia,hypokalemia,hyperkalemia,hyponatremia,metabolic alkalosis,metabolic acidosis, andhyperuricemia.[17]

Adverse effectDiureticsSymptoms
hypovolemia
hypokalemia
hyperkalemia
hyponatremia
metabolic alkalosis
metabolic acidosis
hypercalcemia
hyperuricemia

Abuse in sports

[edit]

A common application of diuretics is for the purposes of invalidatingdrug tests.[22] Diuretics increase the urine volume and dilutedoping agents and their metabolites. Another use is to rapidly lose weight to meet aweight category in sports likeboxing andwrestling.[23][24]

See also

[edit]

References

[edit]
  1. ^Shah, Shaukat; Khatri, Ibrahim; Freis, Edward D. (1978). "Mechanism of antihypertensive effect of thiazide diuretics".American Heart Journal.95 (5):611–618.doi:10.1016/0002-8703(78)90303-4.PMID 637001.
  2. ^Ballew JR, Fink GD (September 2001). "Characterization of the antihypertensive effect of a thiazide diuretic in angiotensin II-induced hypertension".Journal of Hypertension.19 (9):1601–6.doi:10.1097/00004872-200109000-00012.PMID 11564980.S2CID 8531997.
  3. ^"Diuretics".TheDrugMonitor.com. Archived from the original on January 17, 2008.
  4. ^Julio D. Duarte; Rhonda M. Cooper-DeHoff (April 1, 2011)."Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics".Expert Review of Cardiovascular Therapy.8 (6):793–802.doi:10.1586/erc.10.27.PMC 2904515.PMID 20528637.
  5. ^Shankaran S, Liang KC, Ilagan N, Fleischmann L (April 1995). "Mineral excretion following furosemide compared with bumetanide therapy in premature infants".Pediatr. Nephrol.9 (2):159–62.doi:10.1007/BF00860731.PMID 7794709.S2CID 21202583.
  6. ^Bakhireva LN, Barrett-Connor E, Kritz-Silverstein D, Morton DJ (June 2004). "Modifiable predictors of bone loss in older men: a prospective study".Am J Prev Med.26 (5):436–42.doi:10.1016/j.amepre.2004.02.013.PMID 15165661.
  7. ^abChampe, Pamela C.; Richard Hubbard Howland; Mary Julia Mycek; Harvey, Richard P. (2006).Pharmacology. Philadelphia: Lippincott William & Wilkins. p. 269.ISBN 978-0-7817-4118-7.
  8. ^Rejnmark L, Vestergaard P, Pedersen AR, Heickendorff L, Andreasen F, Mosekilde L (January 2003). "Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women".Eur. J. Clin. Invest.33 (1):41–50.doi:10.1046/j.1365-2362.2003.01103.x.PMID 12492451.S2CID 36030615.
  9. ^Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L (January 2006)."Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide".J. Bone Miner. Res.21 (1):163–70.doi:10.1359/JBMR.051003.PMID 16355285.S2CID 41216704.
  10. ^Du, Xiaoping.DiureticsArchived April 7, 2006, at theWayback Machine. Department of Pharmacology, University of Illinois at Chicago.
  11. ^Mutschler, Ernst (1995).Drug actions: basic principles and therapeutic aspects. Stuttgart, German: Medpharm Scientific Pub. p. 460.ISBN 978-0-8493-7774-7.
  12. ^Ali SS, Sharma PK, Garg VK, Singh AK, Mondal SC (Apr 2012). "The target-specific transporter and current status of diuretics as antihypertensive".Fundam Clin Pharmacol.26 (2):175–9.doi:10.1111/j.1472-8206.2011.01012.x.PMID 22145583.S2CID 43171023.
  13. ^Ajay K. Singh; Gordon H. Williams (12 January 2009).Textbook of Nephro-Endocrinology. Academic Press. pp. 250–251.ISBN 978-0-08-092046-7.
  14. ^L. Kovács; B. Lichardus (6 December 2012).Vasopressin: Disturbed Secretion and Its Effects. Springer Science & Business Media. pp. 179–180.ISBN 978-94-009-0449-1.
  15. ^Schrier, Robert W.; Gross, Peter; Gheorghiade, Mihai; Berl, Tomas; Verbalis, Joseph G.; Czerwiec, Frank S.; Orlandi, Cesare (2006-11-16). "Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia".New England Journal of Medicine.355 (20):2099–2112.doi:10.1056/NEJMoa065181.hdl:2437/157922.ISSN 0028-4793.PMID 17105757.
  16. ^Reilly, Timothy; Chavez, Benjamin (2009-10-01)."Tolvaptan (samsca) for hyponatremia: is it worth its salt?".Pharmacy and Therapeutics.34 (10):543–547.PMC 2799145.
  17. ^abcdefghijklmnopqrstuvwxyzaaabacadaeafagahaiajakalamanaoapaqarBoron, Walter F. (2004).Medical Physiology: A Cellular And Molecular Approach. Elsevier/Saunders. p. 875.ISBN 978-1-4160-2328-9.
  18. ^Maughan RJ, Griffin J (December 2003)."Caffeine ingestion and fluid balance: a review"(PDF).Journal of Human Nutrition and Dietetics.16 (6):411–20.doi:10.1046/j.1365-277X.2003.00477.x.PMID 19774754.S2CID 41617469. Archived fromthe original(PDF) on 8 March 2019.
  19. ^O'Connor A (4 March 2008)."Really? The claim: caffeine causes dehydration".New York Times. Retrieved3 August 2009.
  20. ^Armstrong LE, Casa DJ, Maresh CM, Ganio MS (July 2007). "Caffeine, fluid-electrolyte balance, temperature regulation, and exercise-heat tolerance".Exercise and Sport Sciences Reviews.35 (3):135–40.doi:10.1097/jes.0b013e3180a02cc1.PMID 17620932.S2CID 46352603.
  21. ^Maughan RJ, Watson P, Cordery PA, Walsh NP, Oliver SJ, Dolci A, et al. (March 2016)."A randomized trial to assess the potential of different beverages to affect hydration status: development of a beverage hydration index".The American Journal of Clinical Nutrition.103 (3):717–23.doi:10.3945/ajcn.115.114769.hdl:1893/22892.PMID 26702122.S2CID 378245.
  22. ^Bahrke, Michael (2002).Performance-Enhancing Substances in Sport and Exercise.
  23. ^Agence France Presse (2012-07-17)."UCI announces adverse analytical finding for Frank Schleck". VeloNews. Retrieved2012-07-18.
  24. ^Cadwallader AB, de la Torre X, Tieri A, Botrè F (September 2010)."The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis".British Journal of Pharmacology.161 (1):1–16.doi:10.1111/j.1476-5381.2010.00789.x.PMC 2962812.PMID 20718736.

External links

[edit]
Sulfonamides
(andetacrynic acid)
CA inhibitors (atPT)
Loop (Na-K-Cl atAL)
Thiazides (Na-Cl atDCT,
Calcium-sparing)
Thiazide-likes (primarilyDCT)
Potassium-sparing (atCD)
ESC blockers
Aldosterone antagonists
Osmotic diuretics (PT,DL)
Vasopressin receptor inhibitors
(DCT andCD)
Other
Combination products
Major chemical drug groups – based upon theAnatomical Therapeutic Chemical Classification System
gastrointestinal tract
/metabolism (A)
blood and blood
forming organs (B)
cardiovascular
system
(C)
skin (D)
genitourinary
system
(G)
endocrine
system
(H)
infections and
infestations (J,P,QI)
malignant disease
(L01–L02)
immune disease
(L03–L04)
muscles,bones,
andjoints (M)
brain and
nervous system (N)
respiratory
system
(R)
sensory organs (S)
otherATC (V)
Medications used in the management ofpulmonary arterial hypertension (B01,C02)
Prostacyclin analogues
Endothelin receptor antagonists
PDE5 inhibitors
sGC stimulators
Adjunctive therapy
Authority control databases: NationalEdit this at Wikidata
Retrieved from "https://en.wikipedia.org/w/index.php?title=Diuretic&oldid=1267722848"
Category:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp